Skip to content

Airway Deadspace in Children: Air-Q Versus Endotracheal Tube

A Prospective Comparison of the Airway Deadspace Associated With the Air-Q® and Endotracheal Tube Using Volumetric Capnography in Young Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03785977
Enrollment
62
Registered
2018-12-24
Start date
2019-03-25
Completion date
2019-08-09
Last updated
2020-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Deadspace

Keywords

Ventilation, pediatrics, airway management, respiration

Brief summary

The objective of this study will be to measure the airway deadspace associated with use of appropriately sized an AirQ, a commonly used supraglottic airway in young children weighing between 5 and 20 kg and compare that to the airway deadspace associated with use of an endotracheal tube (ETT) in similarly sized children undergoing controlled ventilation.

Detailed description

There is an increasing interest in the use of supraglottic airway devices in progressively younger and younger patients. One issue that has not been well evaluated is the contribution of these devices to airway dead space in young children and infants. Volumetric capnography is the only non-invasive technology available at the current time to evaluate airway deadspace. Volumetric capnography essentially monitors the flow of CO2 over time and from the expired waveform one can determine different respiratory parameters including dead space. This is clinically important in young children as the clinician begins to evaluate whether or not to use an endotracheal tube or supraglottic airway in these patients. To perform this investigation the study team will use volumetric capnography to examine the airway dead space associated with these devices during and elective general surgery and urologic procedures in healthy children between the ages of 0 and 6 years of age (roughly 5-20 kg). Participants in the study will be given ETT or Air-Q as an intervention, but the investigator does not assign specific interventions to the study participants.

Interventions

None listed

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients between the ages of 3 months and 6 years of age weighing between 5 and 20 kg * Patient presenting outpatient urologic or general surgery

Exclusion criteria

* History of difficult airway/intubation * Patients suspected to have a difficult airway. * Morbid obesity BMI \>39 * Emergency status of surgery * Patients exposed to second hand smoke * Patients with Asthma * Patients with a URI symptom such as nasal drainage, cough, or fever within 7 days of the date of surgery * History of Prematurity

Design outcomes

Primary

MeasureTime frameDescription
Mean Value of Airway Dead Space10 minutesA mean value observed over the first 10 minutes following placement of the ETT or the AirQ at the beginning of the case will be recorded.

Secondary

MeasureTime frameDescription
Lung Compliance measured by Respironics NM3 respiratory monitors10 minutesThe values of lung compliance will be collected and reported.
Airway Resistance measured by Respironics NM3 respiratory monitors10 minutesThe value of resistance to flow in the airways will be collected and reported
Volume of Carbon Dioxide Associated with the Devices10 minutesThe volume of carbon dioxide associated with the devices will be recorded and reported.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026